Kindstar Globalgene Technology, Inc. (Kindstar Global) announced amendments to the partnership agreement originally disclosed on 12 November 2023.

The partnership, established on 20 December 2023, will now run until 8 May 2029. Within this term, the investment period has been lengthened from two to three years, commencing 8 May 2024, followed by a two-year payback period. Any extension beyond these phases requires unanimous partner consent, with the combined investment and payback periods capped at six years in total.

To reflect the additional third investment year, the annual management fee for that year will mirror the payback-period rate, set at 1.5 % of the fund’s total cost of remaining investment as of the prior year-end.

All other provisions of the original partnership agreement remain unchanged. The board approved the amendments on 7 May 2026.